Avenue Therapeutics Inc. logo

Avenue Therapeutics Inc. (ATXI)

Market Open
12 Aug, 16:38
NASDAQ (CM) NASDAQ (CM)
$
0. 27
+0.01
+5.8408%
$
990.14K Market Cap
- P/E Ratio
- Div Yield
154 Volume
-0.97 Eps
$ 0.26
Previous Close
Add Transaction
Day Range
0.27 0.27
Year Range
0.15 0.97
Want to track ATXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
13 May 2026
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
30 Mar 2026
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
13 Nov 2025
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
7 Aug 2025
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
13 May 2025
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
17 Mar 2025
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
11 Nov 2024
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
8 Aug 2024
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
24 Jun 2024
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
10 May 2024
-
-
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
28 Mar 2024
-
0.06
Avenue Therapeutics Inc. logo
ATXI Avenue Therapeutics Inc.
1 Nov 2023
-
-

ATXI Earnings Reports FAQ

What is the earnings per share (EPS) for ATXI?

The current EPS is -0.97.

What is the company's earnings growth rate?

Avenue Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Avenue Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Avenue Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ATXI at this time, as Avenue Therapeutics Inc has no recent EPS data to calculate it.